During the past decade, Ain Shams University Hospitals conducted 302 clinical trials. In the 10-year time frame, 302 clinical trials started and 10 clinical trials were completed, i.e. on average, 3.3% percent of trials that started reached the finish line to date. In the past 5 years, 152 clinical trials started and 4 clinical trials were completed. i.e. 2.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ain Shams University Hospitals" #1 sponsor was "Ain Shams University" with 220 trials, followed by "Ain Shams Maternity Hospital" with 59 trials sponsored, "Cairo University" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Agios Pharmaceuticals, Inc." with 3 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ain Shams University Hospitals" #1 collaborator was "Ain Shams University" with 4 trials as a collaborator, "Ain Shams Maternity Hospital" with 2 trials as a collaborator, "Ain Shams University hospitals" with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Ain Shams University Hospitals" are "Anesthesia" (11 trials), "Post Operative Pain" (5 trials), "Preterm Birth" (5 trials), "Analgesia" (4 trials) and "Placenta Previa" (4 trials). Many other conditions were trialed in "Ain Shams University Hospitals" in a lesser frequency.

Most popular intervention types in "Ain Shams University Hospitals" are "Drug" (179 trials), "Procedure" (65 trials), "Other" (43 trials), "Device" (24 trials) and "Diagnostic Test" (20 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Misoprostol" (16 trials), "Dexmedetomidine" (8 trials), "Placebo Oral Tablet" (8 trials) and "Bupivacaine" (7 trials). Other intervention names were less common.

The vast majority of trials in "Ain Shams University Hospitals" are 182 trials for "Female" genders, 139 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are 55 active trials in "Ain Shams University Hospitals". 4 are not yet recruiting, 41 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 177 completed trials in Ain Shams University Hospitals, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ain Shams University Hospitals, 14 "Phase 1" clinical trials were conducted, 52 "Phase 2" clinical trials and 67 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 57 trials, and there were also 88 trials that are defined as “Not Applicable".